ADMA BiologicsvsAmgen

ADMA and AMGN stock compared: price, dividend, valuation and results, from SEC filings.

ADMA

ADMA Biologics Inc

$13.47

Value $3.0B

-1.54%
ADMA's page

AMGN

Amgen Inc.

$462.32

Value $249B

-0.72%
AMGN's page

ADMA Biologics (ADMA) has a market value of $3.0B and Amgen (AMGN) $249B. Over the last year, with dividends, ADMA moved -13.4% and AMGN +41.1%. The P/E is 16.4 for ADMA and 26.5 for AMGN. Dividend yield: ADMA none, AMGN 2.15%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ADMA$3.0B

    AMGN$249B

    AMGN is 83 times ADMA

  • Revenue, 12 months

    ADMA$519M

    AMGN$38.9B

    AMGN is 75 times ADMA

  • Net income, 12 months

    ADMA$182M

    AMGN$9.4B

    AMGN is 51 times ADMA

  • Operating margin

    ADMA46.5%

    AMGN32.4%

    14.1 points apart

  • ROIC

    ADMA32.6%

    AMGN16.2%

    16.4 points apart

  • P/E

    ADMA16.4

    AMGN26.5

    AMGN is 1.6 times ADMA

  • Dividend yield

    ADMA0.0%

    AMGN2.2%

    2.2 points apart

  • 5-year return

    ADMA+769.0%

    AMGN+158.3%

    610.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ADMA+769.2%

AMGN+158.3%

05001000150020222023202420252026
Returns by period
PeriodADMAWith dividendsAMGNWith dividends
1 year since November 14, 2025-13.4%Price -13.4%+41.1%Price +37.3%
3 years since November 16, 2023+253.5%+52.3% a yearPrice +253.5%+86.6%+23.1% a yearPrice +71.9%
5 years since November 15, 2021+769.0%+54.1% a yearPrice +769.0%+158.3%+20.9% a yearPrice +122.9%
10 years since November 16, 2016+119.4%+8.2% a yearPrice +119.4%+320.0%+15.4% a yearPrice +214.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ADMAADMA BiologicsAMGNAmgen

Valuation

ADMAAMGN
Valuation
Price$13.47$462.32
Market value$3.0B$249B
Enterprise value (EV)$3.1B$290B
P/E16.426.5
P/E, 5-year median–23.0
P/B6.817.4
EV/EBIT12.723.0
Free cash flow yield4.5%3.8%

Results and growth

ADMAAMGN
Results and growth
Revenue, 12 months$519M$38.9B
Net income, 12 months$182M$9.4B
Free cash flow, 12 months$133M$9.6B
Earnings per share, 12 months$0.77$17.25
Revenue growth, year on year19.6%10.0%
Revenue growth a year, past+64.6%over 5 years+7.6%over 5 years
EPS growth a year, past–+2.9%over 5 years

Margins and returns on capital

ADMAAMGN
Margins and returns on capital
Gross margin68.5%70.9%
Operating margin46.5%32.4%
Net margin35.1%24.1%
ROIC32.6%16.2%
ROE42.5%87.8%

Balance sheet

ADMAAMGN
Balance sheet
Cash$125M$13.2B
Total debt$203M$54.0B
Net debt / EBITDA0.32.3
Interest cover22.8×4.8×

Dividends and buybacks

ADMAAMGN
Dividends and buybacks
Dividend yield–2.2%
Dividend per share, 12 months–$9.94
Dividend growth a year, past–+8.1%over 5 years
Buyback yield1.1%–
Shareholder yield1.1%2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ADMA or AMGN

Didn't find what you were looking for?

Ask us
Which is bigger, ADMA Biologics or Amgen?

By market value, Amgen ($249B) is about 83.4 times ADMA Biologics ($3.0B), at today's prices.

How did ADMA and AMGN stock do over the last 10 years?

Since November 16, 2016, ADMA's price moved +119.4% and AMGN's +214.0%. With dividends: ADMA +119.4% (+8.2% a year), AMGN +320.0% (+15.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ADMA or AMGN?

The dividend yield at today's price is none for ADMA Biologics and 2.15% for Amgen. Over the last twelve months they paid – and $9.94 per share.

What is the P/E of ADMA and AMGN?

At today's price, the P/E is 16.4 for ADMA and 26.5 for AMGN. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, ADMA Biologics or Amgen?

Over the last twelve months, the net margin was 35.1% for ADMA Biologics and 24.1% for Amgen, and the operating margin 46.5% and 32.4%. Revenue was $519M and $38.9B.

Which is the better investment, ADMA Biologics or Amgen?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.